Tacrolimus-induced reversible posterior leukoencephalopathy syndrome in a child with nephrotic syndrome: a case report

Key Points

• Tacrolimus can cause posterior leukoencephalopathy syndrome early in treatment, requiring prompt attention.
• In this case, neurological symptoms were observed before stable drug concentrations were achieved.
• Vigilant clinical monitoring is essential for early detection of symptoms related to neurological complications.
• Timely intervention is critical to prevent potential long-term effects from tacrolimus-induced PRES.

Abstract